Individualized Treatments in Adults With Relapsed/Refractory Cancers

Completed · Not applicable

Conditions studied: Refractory Cancer, Relapsed Cancer

In brief

A personalized cancer medicine approach would address therapy resistance, cancer metastasis, and limited options after standard of care is exhausted in advanced cancer participants. This approach may reduce the barriers to approved therapeutic assignment currently limited to a particular cancer type or patient demographic.

Key facts

Study ID
NCT06024603
Run by
Case Comprehensive Cancer Center
People needed
36
Starts
2023-11-20
Expected to finish
2025-12-31
Last updated by the study team
2026-07-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.